Skip to main content
ES
v1.2
Log in
A

Aurobindo Pharma

AUROBINDO PHARMANSE
₹1,677+0.00 (+0.00%)
Market Cap
₹95,626Cr.
P/E Ratio
25.3
P/B Ratio
2.57
EPS (TTM)
₹66.28
Div Yield
0.24%
ROCE
12.9%
ROE
10.1%
52W Low: ₹1,08052W High: ₹1,740
Themes:💊 Pharma & CDMO
Appears in 1 screen
🛡️Low-Volatility Defensives
77
Descriptive screens built from published data — not investment advice.

At a glance

  • Sales have grown 11.0% a year over three years.
  • Debt is 0.21× its shareholders’ equity.

From reported financials and exchange prices. Descriptive only, not advice.

Aurobindo_Pharma — Price
Interval
||
Style
Failed: 503

Evenstocks Score

Middle third
5/ 10Overall
5/ 10Valuation
5/ 10Quality
5/ 10Fundamental
5/ 10Growth

Investment Checklist

Quick assessment based on key parameters
Performance
N/ATrailing return unavailable
Valuation
P/E 25.3P/E: 25.3 | P/B: 2.57
Growth
GrowingSales CAGR — 3Y: 11% · 1Y: 9%
Profitability
ModerateROCE: 12.9% | ROE: 10.1%

Key Metrics

Valuation
PEG Ratio 1.10
Price / Sales 2.74x
Price / FCF 38.8x
Book Value ₹652
Margins & returns
Operating Margin 20%
Net Margin 10.6%
Return on Assets 6.4%

Frequently Asked Questions

MarketsPortfolioChart